Under disclosed annual results, sales fell from KRW 82.9 billion in 2023 to KRW 61.7 billion in 2024 (down 25.5% year on year) before rising to KRW 67.4 billion in 2025 (up 9.2%). Within 2023 to 2025, 2023 was the largest year and 2024 the smallest.
Operating profit dropped from KRW 4.52 billion in 2023 to KRW 1.72 billion in 2024 (down 61.9%), and then became an operating loss of KRW 1.72 billion in 2025, a swing from profit to loss year on year. The operating margin fell from 5.5% in 2023 to 2.8% in 2024 and -2.6% in 2025.
Net income attributable to controlling shareholders fell from KRW 4.25 billion in 2023 to KRW 1.75 billion in 2024 (down 58.8%), and became a net loss of KRW 113 million in 2025. Net income including non-controlling interests moved in the same direction, ending at a net loss of KRW 113 million in 2025.
Sales grew in 2025, but margins slid into loss. Press coverage has pointed to research and development spending as a driver: a first-quarter 2025 report said R&D approached 10% of sales, up from 4.4% in 2023 and 6.8% in 2024.
The company said it was temporarily sacrificing profitability because development costs were concentrated in that period.
By quarter, the operating loss of KRW 538 million in the third quarter of 2025 widened to KRW 1.32 billion in the fourth quarter and KRW 1.44 billion in the first quarter of 2026, then narrowed to KRW 1.12 billion in the second quarter and KRW 829 million in the third quarter of 2026.
The third quarter of 2026 nonetheless showed a wider loss than a year earlier. Over the last four quarters, the net loss attributable to controlling shareholders totaled KRW 3.97 billion, while quarterly sales ranged from KRW 13 billion to KRW 20.2 billion. One media outlet had forecast 2025 sales of KRW 91 billion, against disclosed sales of KRW 67.4 billion.